CODX vs IR
Co-Diagnostics, Inc. Common Stock (CODX) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
CODX currently screens at market cap $31.4M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the CODX and IR stock pages for the full models.
Not investment advice.